Cyclic HPMPC
Cyclic HPMPC is a potent antiviral agent. Cyclic HPMPC can increase arterial oxygen saturation levels in lethal vaccinia virus (IHD strain) -infected mice. Cyclic HPMPC improves the outcome of congenital guinea pig cytomegalovirus (GPCMV) infection and decreases viral replication in guinea pig model[1][2].
Product Specifications
CAS Number
127757-45-3
UNSPSC
12352005
Target
CMV; Orthopoxvirus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cyclic-hpmpc.html
Solubility
10 mM in DMSO
Smiles
O=C1N(C=CC(N)=N1)C[C@H](OC2)CO[P]2(O)=O
Molecular Formula
C8H12N3O5P
Molecular Weight
261.17
References & Citations
[1]Smee DF, et al. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. Int J Antimicrob Agents. 2004;23 (5) :430-437.|[2]Bravo FJ, et al. Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection. J Infect Dis. 2006;193 (4) :591-597.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
589812 96 Tests
Tetracycline (TTC) BioAssayTM ELISA Kit (General) (Sumycin)
Sign In for Pricing
View Details MBS6249268-02 5x 0.1 mL
Pseudomonas aeruginosa, serotype 2B (Biotin)
Sign In for Pricing
View Details 
ARM0689 500 mL
Rabbit Abdominal Aortic Adventitial Fibroblast Medium
Sign In for Pricing
View Details 
GTR15350525 1 Vial
Lentiviral human NFIX shRNA (UAS) - Lentiviral human NFIX shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details